Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for AMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 200.00M
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 6.36B
December 31, 2021 1.443B
September 30, 2021 1.08B
June 30, 2021 1.581B
March 31, 2021 871.00M
December 31, 2020 1.205B
September 30, 2020 765.00M
June 30, 2020 555.00M
Date Value
March 31, 2020 961.00M
December 31, 2019 1.094B
September 30, 2019 1.161B
June 30, 2019 2.415B
March 31, 2019 3.032B
December 31, 2018 2.124B
September 30, 2018 1.729B
June 30, 2018 3.244B
March 31, 2018 10.70B
December 31, 2017 789.00M
September 30, 2017 809.00M
June 30, 2017 976.00M
March 31, 2017 586.00M
December 31, 2016 928.00M
September 30, 2016 764.00M
June 30, 2016 542.00M
March 31, 2016 676.00M
December 31, 2015 166.00M
September 30, 2015 731.00M
June 30, 2015 442.00M
March 31, 2015 446.00M
December 31, 2014 105.00M
September 30, 2014 -54.00M
June 30, 2014 -61.00M
March 31, 2014 -38.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. 346.00M
Regeneron Pharmaceuticals, Inc. 1.120B
AbbVie, Inc. 9.00M
Biogen, Inc. -6.00M
Vertex Pharmaceuticals, Inc. 421.80M